Recent Developments in Immuno-oncology. Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events. Expires on April 13, 2021 Eligible for Oncology, Hematology, Allergy, Clinical Immunology, Medical Genetics, and Internal Medicine Specialists. IPOKRATE team has selected this CME activity. Register, complete & earn CME credits...